NYSE$CTEV

Claritev Corp · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

MultiPlan's Q4 2021 results showed record revenues, net income, and adjusted EBITDA, driven by increased volumes and strong savings performance.

MultiPlan reported record fourth quarter and full year 2021 results, with Q4 revenues of $298.3 million, net income of $24.9 million, and adjusted EBITDA of $223.6 million. The growth was driven by increased volumes and strong savings performance across all lines of business.

  • Q4 2021 revenues reached $298.3 million, a 16.8% increase over Q4 2020.
  • Net income for Q4 2021 was $24.9 million, compared to a net loss of $173.3 million in Q4 2020.
  • Adjusted EBITDA for Q4 2021 was $223.6 million, compared to $195.1 million in Q4 2020.
  • The company processed $32.2 billion in claims during Q4 2021, identifying potential medical cost savings of approximately $5.7 billion.

Headline financials

Total Revenue

$298M

Previous: $255M+16.8%
EPS (adj)

$1.60

Previous: -$8.80+118.2%
Capital Expenditures

$27.4M

Previous: $21.5M+27.5%
Free Cash Flow

$5.87M

Previous: $358M-98.4%
Net Income

$24.9M

Previous: -$523M+104.8%
Operating Income

$110M

Previous: -$121M+190.5%
Gross Profit

$252M

Previous: $693M-63.7%
Cash & Equivalents

$185M

Previous: $127M+46.2%
Total Assets

$8.22B

Previous: $8.28B-0.8%
Stock-Based Comp

$4.82M

Previous: $106M-95.5%

Revenue & EPS history

Multiplan · Revenue · Quarterly

$298M

Q4 2021+16.8%vs Q4 2020
Beat estimate in 8 of 9 quarters(89%)
ActualEstimate

Forward guidance

MultiPlan provided full year 2022 revenue guidance of $1,160 million to $1,200 million and Adjusted EBITDA guidance of $850 million to $875 million.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

-6.5%

Avg return

Earnings day

-5.1%

Avg return

5 days after

-3.8%

Avg return

30 days after

36%

9 / 25 earnings

Positive

+20.8%

Q1 2021

Best reaction

-32.8%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-8.8%+7.7%-2.6%
Q4 2025-31.8%-42.0%-31.4%
Q3 2025+11.8%-5.4%-45.2%
Q1 2025+4.2%+7.5%+95.1%
Q4 2024-32.8%-28.1%-24.8%
Q3 2024-6.5%-3.4%-22.6%
Q2 2024-23.9%-10.2%-47.8%
Q1 2024+10.9%-1.5%-36.6%
Q4 2023-0.9%-13.4%-27.6%
Q3 2023-6.5%-9.7%-14.3%
Q2 2023-8.9%-14.0%-17.8%
Q1 2023-5.4%+21.0%+97.6%
Q4 2022-10.2%+10.0%+6.0%
Q3 2022-27.8%-18.3%-31.1%
Q2 2022-12.4%-13.4%-33.1%
Q1 2022+1.0%+18.4%+27.4%
Q4 2021-8.0%-18.9%-14.4%
Q3 2021+0.2%-11.0%-4.3%
Q2 2021-6.2%-10.5%-20.6%
Q1 2021+20.8%+27.0%+45.5%
Q2 2020+0.5%-0.2%+1.9%
Q4 2020-18.6%-20.3%-19.7%
Q3 2020-4.6%+0.7%+20.8%
Q1 2020+0.5%+0.7%+2.3%
Q4 2019+0.5%+0.7%+2.3%
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro